Citations |
1. Biomaterials 34, 9171 (2013). http://dx.doi.org/10.1016/j.biomaterials.2013.08.039 2. J Control Release (2013) http://dx.doi.org/10.1016/j.jconrel.2013.10.002 3. Biomaterials (2013), http://dx.doi.org/10.1016/j.biomaterials.2013.09.094 4. Biomaterials (2013), http://dx.doi.org/10.1016/j.biomaterials.2013.09.089 5. International Journal of Nanomedicine 8, 2473-2485 (2013). 6. Bioconjugate Chemistry (2013) doi: 10.1021/bc400055h 7. International Journal of Pharmaceutics (2013), http://dx.doi.org/10.1016/j.ijpharm.2013.05.015 8. Pharm Res (2013) doi: 10.1007/s11095-013-1055-y 9. Biomaterials (2013), http://dx.doi.org/10.1016/j.biomaterials.2013.03.097 10. International Journal of Nanomedicine 8, 1573-1593 (2013) 11. International Journal of Nanomedicine 8, 1463-1476 (2013) 12. Biomaterials (2013), http://dx.doi.org/10.1016/j.biomaterials.2013.03.036 13. Biomaterials (2013), http://dx.doi.org/10.1016/j.biomaterials.2013.02.013 14. Biomaterials (2013), http://dx.doi.org/10.1016/j.biomaterials.2012.12.049 15. Biomaterials (2012), http://dx.doi.org/10.1016/j.biomaterials.2012.12.012 16. Biomaterials (2013), http://dx.doi.org/10.1016/j.biomaterials.2012.11.016 17. International Journal of Nanomedicine 7, 163-175 (2012) 18. J. Control. Release (2012) doi:10.1016/j.jconrel.2011.12.017 19. Pharm Res (2011) doi: 10.1007/s11095-011-0641-0 20. Biomaterials (2011) doi:10.1016/j.biomaterials.2011.10.035 21. International Journal of Pharmaceutics (2011) doi:10.1016/j.ijpharm.2011.09.008 22. Molecular Pharmaceutics (2011) doi: 10.1021/mp200100f 23. International Journal of Pharmaceutics (2011) doi:10.1016/j.ijpharm.2011.08.052 24. International Journal of Pharmaceutics (2011) doi:10.1016/j.ijpharm.2011.07.021 25. Molecular Pharmaceutics (2010) doi: 10.1021/mp100277h 26. Journal of Controlled Release (2013), http://dx.doi.org/10.1016/j.jconrel.2013.10.026 27. Biomaterials (2013), http://dx.doi.org/10.1016/j.biomaterials.2013.09.062 28. PLoS ONE (2013), doi:10.1371/journal.pone.0085003 29. Int J Pharmaceut (2013), http://dx.doi.org/10.1016/j.ijpharm.2013.12.016 30. Journal of Drug Targeting (2014), http://informahealthcare.com/doi/abs/10.3109/1061186X.2013.851683 31. ACS Nano (2014), doi: 10.1021/nn405155b 32. Molecular Pharmaceutics (2014), doi: 10.1021/mp400751g 33. Int J Pharmaceut (2014), http://dx.doi.org/10.1016/j.ijpharm.2014.03.012 34. Biomaterials (2014), http://dx.doi.org/10.1016/j.biomaterials.2014.03.012 35. Int J Pharmaceut (2014), http://dx.doi.org/10.1016/j.ijpharm.2014.04.008 36. Biomaterials (2014), http://dx.doi.org/10.1016/j.biomaterials.2014.03.036 37. Drug Delivery (2014), doi:10.3109/10717544.2014.903580 38. Biomaterials (2014), http://dx.doi.org/10.1016/j.biomaterials.2014.04.031 39. Pharm Res. (2014), doi: 10.1007/s11095-014-1400-9 40. Small (2014), doi: 10.1002/smll.201302786 41. Biomaterials (2014), http://dx.doi.org/10.1016/j.biomaterials.2014.04.117 42. Biomaterials (2014), http://dx.doi.org/10.1016/j.biomaterials.2014.06.022 43. Mol. Pharmaceutics (2014), dx.doi.org/10.1021/mp500113p 44. Vaccine (2014), http://dx.doi.org/10.1016/j.vaccine.2014.07.081 45. Journal of controlled release (2014), http://dx.doi.org/10.1016/j.jconrel.2014.09.029 46. Biomaterials (2014), http://dx.doi.org/10.1016/j.biomaterials.2014.09.008 47. International Journal of Nanomedicine 9, 5261-5271(2014). 48. Journal of pharmaceutical sciences (2014), doi: 10.1002/jps.24291 49. Biomaterials (2014), http://dx.doi.org/10.1016/j.biomaterials.2014.11.044 50. Int J Pharmaceut (2014), http://dx.doi.org/10.1016/j.ijpharm.2014.12.039 51. Acta Biomater (2015), http://dx.doi.org/10.1016/j.actbio.2015.01.010 52. Polym. Chem. (2015), doi: 10.1039/C4PY01422G 53. Biointerfaces (2015), http://dx.doi.org/10.1016/j.colsurfb.2015.02.041 54. ONCOLOGY LETTERS (2015), doi: 10.3892/ol.2015.3242 55. Acta Biomaterialia (2015), http://dx.doi.org/10.1016/j.actbio.2015.05.021 56. Drug Delivery (2015), http://informahealthcare.com/doi/abs/10.3109/10717544.2015.1040527 57. Journal of Drug Targeting (2015), doi:10.3109/1061186X.2015.1058800 58. Journal of drug targeting (2015), doi:10.3109/1061186X.2015.1064435 59. Nanomedicine (2015), doi:10.2217/nnm.15.106 60. Molecular Pharmaceutics (2015), doi: 10.1021/acs.molpharmaceut.5b00222 61. Bio-Medical Materials and Engineering 26 (2015), doi: 10.3233/BME-151384 62. ACS Appl. Mater. Interfaces (2015), doi: 10.1021/acsami.5b06043 63. International Journal of Pharmaceutics (2015), doi:10.1016/j.ijpharm.2015.12.013 64. RSC Advances (2015), doi: 10.1039/c5ra22233h 65. Applied Materials Interfaces (2015), doi: 10.1021/acsami.5b09934 |
Description |
DiIC 18(7); 1, 1'-dioctadecyl-3, 3, 3', 3'-tetramethylindotricarbocyanine iodide DiR is a lipophilic, near-infrared fluorescent cyanine dye. The dye is useful for labeling cytoplasmic membrane. The two long 18-carbon chains insert into the cell membrane, resulting in specific and stable cell staining with no or minimal dye transfer between cells. A stock solution of the dye can be made in ethanol. Cell staining can be effected using the dye at 1-10 uM concentration and 10-20 min incubation time. Please also see our other cytoplasmic membrane dyes. DiR, DiD, DiI and Neuro-DiO can be used in combination for multicolor imaging. - Ex/Em (MeOH) = 748/780 nm
- μ = 270, 000
- Dark blue-green oily solid soluble in ethanol, DMF or DMSO
- Store at -20°C
- C63H101IN2
- MW: 1013.4
|